GSK PLC (GSK)
40.86
-0.38
(-0.92%)
USD |
NYSE |
Apr 24, 16:00
41.25
+0.39
(+0.95%)
Pre-Market: 07:17
GSK Gross Profit (Quarterly): 6.997B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.997B |
September 30, 2023 | 7.439B |
June 30, 2023 | 6.566B |
March 31, 2023 | 6.087B |
December 31, 2022 | 6.042B |
September 30, 2022 | 6.362B |
June 30, 2022 | 5.975B |
March 31, 2022 | 6.001B |
December 31, 2021 | 5.784B |
September 30, 2021 | 6.358B |
June 30, 2021 | 5.773B |
March 31, 2021 | 6.807B |
December 31, 2020 | -530.41M |
September 30, 2020 | 7.445B |
June 30, 2020 | 6.418B |
March 31, 2020 | 7.551B |
December 31, 2019 | 7.280B |
September 30, 2019 | 7.565B |
June 30, 2019 | 6.647B |
March 31, 2019 | 6.420B |
December 31, 2018 | 6.810B |
September 30, 2018 | 7.107B |
June 30, 2018 | 6.814B |
March 31, 2018 | 6.718B |
December 31, 2017 | 6.747B |
Date | Value |
---|---|
September 30, 2017 | 6.795B |
June 30, 2017 | 6.009B |
March 31, 2017 | 6.033B |
December 31, 2016 | 6.308B |
September 30, 2016 | 6.590B |
June 30, 2016 | 6.332B |
March 31, 2016 | 5.863B |
December 31, 2015 | 5.681B |
September 30, 2015 | 6.079B |
June 30, 2015 | 5.948B |
March 31, 2015 | 5.334B |
December 31, 2014 | 6.576B |
September 30, 2014 | 6.373B |
June 30, 2014 | 6.461B |
March 31, 2014 | 6.403B |
December 31, 2013 | 7.090B |
September 30, 2013 | 6.821B |
June 30, 2013 | 7.136B |
March 31, 2013 | 6.982B |
December 31, 2012 | 7.680B |
September 30, 2012 | 7.008B |
June 30, 2012 | 7.063B |
March 31, 2012 | 7.574B |
December 31, 2011 | 7.902B |
September 30, 2011 | 8.085B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-530.41M
Minimum
Dec 2020
7.565B
Maximum
Sep 2019
6.240B
Average
6.418B
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
AstraZeneca PLC | 9.716B |
Haleon PLC | 1.839B |
Novo Nordisk A/S | 8.060B |
Pfizer Inc | 6.686B |
Sanofi SA | 8.780B |